Nicaise Ndembi Dr. Ndembi is a virologist and public health expert, he serves as the Director of Laboratory Research at the Institute of Human Virology Nigeria (IHVN). He is also Adjunct Associate Professor, Division of Epidemiology and Prevention at the IHV, University of Maryland School of Medicine, US and Research Professor, Global Affairs Section, Kanazawa University, Japan.
Dr. Ndembi has served on several scientific advisory panels and continues to serve as an advisor on HIV drug resistance and control policy to Nigeria’s Federal Ministry of Health. He is a member of the PharmAccess Technical Advisory board for the Pan-African Study for Evaluation of Resistance (PASER) in Africa (Lancet Infectious Diseases 2012), WHO Resistance Network Technical Working Group and Guidelines Dvelopment Group Member (Lancet 2012) and . He has authored/co-authored more than 100 publications in peer reviewed journals. He is the Editor in Chief for the Africa CDC Journal of Public Health in Africa, AIDS Research and Therapy, Associate Editor for Frontiers in Public Health and Section Editor for the African Journal of Laboratory Medicine.
Dr. Ndembi is a member of numerous international review boards and a principal investigator and co-investigator for the US National Health Institute (NIH) grants. Dr. Ndembi main research interest includes HIV vaccine research especially understanding protective immune responses, genomics epidemiology, microbiome, Emerging and Re-Emerging Infectious Diseases, HIV diversity and resistance to Antiretroviral Therapy (ART).
Dr. Ndembi is a graduate of Kanazawa University School of Medicine, Department of Viral Infection and International Public Health.